×
About 1,378 results

ALLMedicine™ Anaplastic Thyroid Carcinoma Center

Research & Reviews  685 results

Non‑invasive monitoring of paclitaxel and lenvatinib efficacy against anaplastic thyroi...
https://doi.org/10.3892/or.2020.7720
Oncology Reports; Aoyama M, Takizawa H et. al.

Sep 18th, 2020 - Anaplastic thyroid carcinoma (ATC) is a rare type of thyroid carcinoma with a poor prognosis. Thus, suitable preclinical tumor models are required for the development of new ATC therapies. In the present study, orthotopic tumor xenograft models we...

The differences of regulatory networks between papillary and anaplastic thyroid carcino...
https://doi.org/10.1080/15384047.2020.1803009
Cancer Biology & Therapy; Pan Z, Li L et. al.

Sep 5th, 2020 - Unlike papillary thyroid cancer (PTC), anaplastic thyroid carcinoma (ATC) is extremely aggressive and rapidly lethal without effective therapies. However, the differences of master regulators and regulatory networks between PTC and ATC remain uncl...

Primary squamous cell carcinoma of thyroid with a novel BRAF mutation and High PDL-1 ex...
https://doi.org/10.1016/j.prp.2020.153146
Pathology, Research and Practice; Torrez M, Braunberger RC et. al.

Aug 27th, 2020 - Primary squamous cell carcinoma of thyroid (SCC-T) is an extremely rare, aggressive neoplasm with median survival of 9 months. Pure squamous morphology with absence of other cell types is required for diagnosis of SCC-T. Clinically, SCC-T behaves ...

Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411939
JAMA Oncology; Maniakas A, Dadu R et. al.

Aug 7th, 2020 - Anaplastic thyroid carcinoma (ATC) historically has a 4-month median overall survival (OS) from time of diagnosis, with disease-specific mortality approaching 100%. The association between recent major advancements in treatment and OS has yet to b...

IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis.
https://doi.org/10.1038/s41379-020-0630-0
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc; Haase J, Misiak D et. al.

Jul 26th, 2020 - Anaplastic thyroid carcinomas (ATC) are rare, but represent the most lethal malignancy of the thyroid. Selective molecular markers and drivers distinguishing ATC from other thyroid carcinomas of follicular origin remain largely unknown, limiting a...

see more →

Guidelines  2 results

American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid C...
https://www.liebertpub.com/doi/10.1089/thy.2012.0302
Robert C. Smallridge

Nov 5th, 2012 - These are the first comprehensive guidelines for ATC and provide recommendations for management of this extremely aggressive malignancy. Patients with stage IVA/IVB resectable disease have the best prognosis, particularly if a multimodal approach.

The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and recommendations for treatments of thyroid cancer
https://www.jstage.jst.go.jp/article/endocrj/advpub/0/advpub_EJ20-0025/_pdf/-char/en
Endocrine Journal;

 The Japan Associations of Endocrine Surgeons has developed the revised version of the Clinical Practice Guidelines for Thyroid Tumors. This article describes the guidelines translated into English for the 35 clinical questions relevant to the t...

see more →

Clinicaltrials.gov  689 results

Non‑invasive monitoring of paclitaxel and lenvatinib efficacy against anaplastic thyroi...
https://doi.org/10.3892/or.2020.7720
Oncology Reports; Aoyama M, Takizawa H et. al.

Sep 18th, 2020 - Anaplastic thyroid carcinoma (ATC) is a rare type of thyroid carcinoma with a poor prognosis. Thus, suitable preclinical tumor models are required for the development of new ATC therapies. In the present study, orthotopic tumor xenograft models we...

Changes in Overall Survival in Patients With Anaplastic Thyroid Carcinoma From 2000–2019
https://ascopost.com/issues/september-10-2020/changes-in-overall-survival-in-patients-with-anaplastic-thyroid-carcinoma-from-2000-2019/

Sep 9th, 2020 - In a single-institution retrospective cohort study reported in JAMA Oncology, Maniakas et al found that overall survival in anaplastic thyroid carcinoma has improved in recent years and identified treatment factors associated with this improvement...

The differences of regulatory networks between papillary and anaplastic thyroid carcino...
https://doi.org/10.1080/15384047.2020.1803009
Cancer Biology & Therapy; Pan Z, Li L et. al.

Sep 5th, 2020 - Unlike papillary thyroid cancer (PTC), anaplastic thyroid carcinoma (ATC) is extremely aggressive and rapidly lethal without effective therapies. However, the differences of master regulators and regulatory networks between PTC and ATC remain uncl...

Primary squamous cell carcinoma of thyroid with a novel BRAF mutation and High PDL-1 ex...
https://doi.org/10.1016/j.prp.2020.153146
Pathology, Research and Practice; Torrez M, Braunberger RC et. al.

Aug 27th, 2020 - Primary squamous cell carcinoma of thyroid (SCC-T) is an extremely rare, aggressive neoplasm with median survival of 9 months. Pure squamous morphology with absence of other cell types is required for diagnosis of SCC-T. Clinically, SCC-T behaves ...

Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411939
JAMA Oncology; Maniakas A, Dadu R et. al.

Aug 7th, 2020 - Anaplastic thyroid carcinoma (ATC) historically has a 4-month median overall survival (OS) from time of diagnosis, with disease-specific mortality approaching 100%. The association between recent major advancements in treatment and OS has yet to b...

see more →

News  2 results

Lichenoid dermatitis with mycosis fungoides features linked to checkpoint inhibitor therapy
https://www.mdedge.com/hematology-oncology/article/205419/immunotherapy/lichenoid-dermatitis-mycosis-fungoides-features?channel=39313
Bianca Nogrady

Jul 28th, 2019 - A patient treated with immune checkpoint inhibitor therapy for thyroid carcinoma presented with lichenoid dermatitis that resembled mycosis fungoides and also showed with monoclonal T-cell receptor gene rearrangement. A case report published in th.

The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and recommendations for treatments of thyroid cancer
https://www.jstage.jst.go.jp/article/endocrj/advpub/0/advpub_EJ20-0025/_pdf/-char/en
Endocrine Journal;

 The Japan Associations of Endocrine Surgeons has developed the revised version of the Clinical Practice Guidelines for Thyroid Tumors. This article describes the guidelines translated into English for the 35 clinical questions relevant to the t...

see more →